Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain

Cell Transplantation

Volumn 17, Issue 7, 2008, Pages 763-773

  Bagga, V ^a   Dunnett, S B ^a   Fricker Gates, R A ^b,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

Ascorbic acid; Dopaminergic neurons; Neuronal survival; Oxidative stress; Parkinson's disease; Transplantation

Indexed keywords

ASCORBIC ACID; OXIDOPAMINE; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE; ANTIOXIDANT; DOPAMINE;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; FEMALE; MESENCEPHALON; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ANIMAL; BRAIN TRANSPLANTATION; DRUG EFFECT; FETAL TISSUE TRANSPLANTATION; HUMAN; MEDIAL FOREBRAIN BUNDLE; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

RATTUS;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; CELL SURVIVAL; DOPAMINE; FEMALE; FETAL TISSUE TRANSPLANTATION; HUMANS; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; NEURONS; OXIDATIVE STRESS; OXIDOPAMINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TYROSINE 3-MONOOXYGENASE;

EID: 58149188538     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786516774     Document Type: Article

References (40)

1. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. Agrawal, A. K.; Chaturvedi, R. K.; Shukla, S.; Seth, K.; Chauhan, S.; Ahmad, A.; Seth, P. K. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. J. Chem. Neuroanat. 28: 253-264; 2004.
3. Annett, L. E.; Martel, F. L.; Rogers, D. C.; Ridley, R. M.; Baker, H. F.; Dunnett, S. B. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 125:228-246; 1994.
4. Annett, L. E.; Torres, E. M.; Clarke, D. J.; Ishida, Y.; Barker, R. A.; Ridley, R. M.; Baker, H. F.; Dunnett, S. B. Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age. Cell Transplant. 6:557-569; 1997.
5. Arakawa, N.; Nemoto, S.; Suzuki, E.; Otsuka, M. Role of hydrogen peroxide in the inhibitory effect of ascorbate on cell growth. J. Nutr. Sci. Vitaminol. (Tokyo) 40:219-227; 1994.
6. Björklund, A.; Dunnett, S. B.; Stenevi, U.; Lewis, M. E.; Iversen, S. D. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199:307-333; 1980.
7. Björklund, A.; Dunnett, S. B. Dopamine neuron systems in the brain: An update. Trends Neurosci. 30:195-202; 2007.
8. Brundin, P.; Isacson, O.; Gage, F. H.; Prochiantz, A.; Björklund, A. The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting. Brain Res. 366:346-349; 1986.
9. Brundin, P.; Barbin, G.; Strecker, R. E.; Isacson, O.; Prochiantz, A.; Björklund, A. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Res. 467:233-243; 1988.
10. Brundin, P.; Björklund, A. Survival of expanded dopaminergic precursors is critical for clinical trials. Nat. Neurosci. 1:537; 1998.
11. Brundin, P.; Karlsson, J.; Emgard, M.; Schierle, G. S.; Hansson, O.; Petersen, A.; Castilho, R. F. Improving the survival of grafted dopaminergic neurones: A review over current approaches. Cell Transplant. 9:179-195; 2000.
12. Clement, M. V.; Ramalingam, J.; Long, L. H.; Halliwell, B. The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid. Redox. Signal. 3:157-163; 2001.
13. Colton, C. A.; Pagan, R; Snell, J.; Colton, J. S.; Cummins, A.; Gilbert, D. L. Protection from oxidation enhances the survival of cultured mesencephalic neurones. Exp. Neurol. 132:54-61; 1995.
14. Dowd, E.; Dunnett, S. B. Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants. Eur. J. Neurosci. 20:1953-1959; 2004.
15. Dunnett, S. B. Transplantation of dopamine neurones. Semin. Neurosci. 4:161-169; 1992.
16. Fahn, S.; Cohen, G. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32: 804-812; 1992.
17. Frodl, E. M.; Nakao, N.; Brundin, P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. NeuroReport 5:2393-2396; 1994.
18. German, D. C.; Manaye, K. F. Midbrain dopaminergic-neurons (nuclei A8, A9, and A10): 3-dimensional reconstruction in the rat. J. Comp. Neurol. 331:297-309; 1993.
19. Grasbon-Frodl, E. M.; Andersson, A.; Brundin, P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurones following glutathione depletion. J. Neurochem. 67:1653-1660; 1996.
20. Grunewald, R. A. Ascorbic acid in the brain. Brain Res. Rev. 18:123-133; 1993.
21. Hagell, P.; Cenci, M. A. Dyskinesias and dopamine cell replacement in Parkinson's disease: A clinical perspective. Brain Res. Bull. 68:4-15; 2005.
22. Hefti, F.; Melamed, E.; Sahakian, B. J.; Wurtman, R. J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA. Pharmacol. Biochem. Behav. 12:185-188; 1980.
23. Kalir, H. H.; Mytilineou, C. Ascorbic acid in mesencephalic cultures: Effects on dopaminergic neurone development. J. Neurochem. 57:458-464; 1991.
24. Lau, T.; Adam, S.; Schloss, P. Rapid and efficient differentiation of dopaminergic neurons from mouse embryonic stem cells. NeuroReport 17:975-979; 2006.
25. Love, R. M.; Branton, R. L.; Karlsson, J.; Brundin, P.; Clarke, D. J. Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurones in vitro and following grafting in an animal model of Parkinson's disease. Cell Transplant. 11:653-662; 2002.
26. Low, W. C.; Triarhou, L. C.; Kaseda, Y.; Norton, J.; Ghetti, B. Functional innervation of the striatum by ventral mesencephalic grafts in mice with inherited nigrostria-tal dopamine deficiency. Brain Res. 435:315-321; 1987.
27. Maries, E.; Kordower, J. H.; Chu, Y.; Collier, T. J.; Sort-well, C. E.; Olaru, E.; Shannon, K.; Steece-Collier, K. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis. 21:165-180; 2006.
28. Nakao, N.; Frodl, E. M.; Duan, W. M.; Widner, H.; Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopamine neurones. Proc. Natl. Acad. Sci. USA 91:12408-12412; 1994.
29. Olanow, C. W. A radical hypothesis for neurodegenera-üon. Trends Neurosci. 16:439-444; 1993.
30. Podmore, I. D.; Griffiths, H. R.; Herbert, K. E.; Mistry, N.; Mistry, P.; Lunec, J. Vitamin C exhibits pro-oxidant properties. Nature 392:559; 1998.
31. Rice, M. E.; Russo-Menna, I. Differential compartmental-ization of brain ascorbate and glutathione between neurones and glia. Neuroscience 82:1213-1223; 1998.
32. Rice, M. E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23:209-216; 2000.
33. Sian, J.; Dexter, D. T.; Lees, A. J.; Daniel, S.; Agid, Y.; Javoy-Agid, F.; Jenner, P.; Marsden, C. D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:348-355; 1994.
34. Sirinathsinghji, D. J.; Dunnett, S. B.; Northrop, A. J.; Morris, B. J. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway III. Reversal by embryonic nigral dopamine grafts. Neuroscience 37:757-766; 1990.
35. Storch, A.; Paul, G.; Csete, M.; Boehm, B. O.; Carvey, P. M.; Kupsch, A.; Schwarz, J. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170:317-325; 2001.
36. Studer, L.; Csete, M.; Lee, S. H.; Kabbani, N.; Walikonis, J.; Wold, B.; McKay, R. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. I. Neurosci. 20:7377-7383; 2000.
37. Ungerstedt, U.; Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485-493; 1970.
38. Yan, J.; Studer, L.; McKay, R. D. Ascorbic acid increases the yield of dopaminergic neurones derived from basic fibroblast growth factor expanded mesencephalic precursors. I. Neurochem. 76:307-311; 2001.
39. Zawada, W. M.; Zastrow, D. J.; Clarkson, E. D.; Adams, F. S.; Bell, K. P.; Freed, C. R. Growth factors improve immediate survival of embryonic dopamine neurones after transplantation into rats. Brain Res. 786:96-103; 1998.
40. Zhou, I.; Bradford, H. F.; Stern, G. M. Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine. Eur. I. Neurosci. 8:2328-2339; 1996.